110 related articles for article (PubMed ID: 38858665)
1. The potential of organoids in renal cell carcinoma research.
Chen Q; Sun X; Li Y; Yang X; Yang X; Xu H; Cai H; Hu J
BMC Urol; 2024 Jun; 24(1):120. PubMed ID: 38858665
[TBL] [Abstract][Full Text] [Related]
2. Establishment of patient-derived three-dimensional organoid culture in renal cell carcinoma.
Na JC; Kim JH; Kim SY; Gu YR; Jun DY; Lee HH; Yoon YE; Choi KH; Hong SJ; Han WK
Investig Clin Urol; 2020 Mar; 61(2):216-223. PubMed ID: 32158973
[TBL] [Abstract][Full Text] [Related]
3. Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma.
Wang B; Xue Y; Zhai W
Front Immunol; 2022; 13():902060. PubMed ID: 35592336
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived renal cell carcinoma organoids for personalized cancer therapy.
Li Z; Xu H; Yu L; Wang J; Meng Q; Mei H; Cai Z; Chen W; Huang W
Clin Transl Med; 2022 Jul; 12(7):e970. PubMed ID: 35802820
[TBL] [Abstract][Full Text] [Related]
5. Three Dimensional Culture of Human Renal Cell Carcinoma Organoids.
Batchelder CA; Martinez ML; Duru N; Meyers FJ; Tarantal AF
PLoS One; 2015; 10(8):e0136758. PubMed ID: 26317980
[TBL] [Abstract][Full Text] [Related]
6. Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.
Grassi L; Alfonsi R; Francescangeli F; Signore M; De Angelis ML; Addario A; Costantini M; Flex E; Ciolfi A; Pizzi S; Bruselles A; Pallocca M; Simone G; Haoui M; Falchi M; Milella M; Sentinelli S; Di Matteo P; Stellacci E; Gallucci M; Muto G; Tartaglia M; De Maria R; Bonci D
Cell Death Dis; 2019 Feb; 10(3):201. PubMed ID: 30814510
[TBL] [Abstract][Full Text] [Related]
7. A synopsis of prostate organoid methodologies, applications, and limitations.
Gleave AM; Ci X; Lin D; Wang Y
Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
[TBL] [Abstract][Full Text] [Related]
8. 3D Tumor Models in Urology.
Neuhaus J; Rabien A; Reinhold A; Koehler L; Berndt-Paetz M
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047203
[TBL] [Abstract][Full Text] [Related]
9. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
10. Engineered organoids for biomedical applications.
Roberto de Barros N; Wang C; Maity S; Peirsman A; Nasiri R; Herland A; Ermis M; Kawakita S; Gregatti Carvalho B; Hosseinzadeh Kouchehbaghi N; Donizetti Herculano R; Tirpáková Z; Mohammad Hossein Dabiri S; Lucas Tanaka J; Falcone N; Choroomi A; Chen R; Huang S; Zisblatt E; Huang Y; Rashad A; Khorsandi D; Gangrade A; Voskanian L; Zhu Y; Li B; Akbari M; Lee J; Remzi Dokmeci M; Kim HJ; Khademhosseini A
Adv Drug Deliv Rev; 2023 Dec; 203():115142. PubMed ID: 37967768
[TBL] [Abstract][Full Text] [Related]
11. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
Qu J; Kalyani FS; Liu L; Cheng T; Chen L
Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
[TBL] [Abstract][Full Text] [Related]
12. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity.
Calandrini C; Schutgens F; Oka R; Margaritis T; Candelli T; Mathijsen L; Ammerlaan C; van Ineveld RL; Derakhshan S; de Haan S; Dolman E; Lijnzaad P; Custers L; Begthel H; Kerstens HHD; Visser LL; Rookmaaker M; Verhaar M; Tytgat GAM; Kemmeren P; de Krijger RR; Al-Saadi R; Pritchard-Jones K; Kool M; Rios AC; van den Heuvel-Eibrink MM; Molenaar JJ; van Boxtel R; Holstege FCP; Clevers H; Drost J
Nat Commun; 2020 Mar; 11(1):1310. PubMed ID: 32161258
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer organoids derived from patients: A platform for tailored drug screening.
Tzeng YT; Hsiao JH; Tseng LM; Hou MF; Li CJ
Biochem Pharmacol; 2023 Nov; 217():115803. PubMed ID: 37709150
[TBL] [Abstract][Full Text] [Related]
14. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
[TBL] [Abstract][Full Text] [Related]
15. [Normal organoids and their applications in cancer research].
Delom F; Le Morvan V; Robert J; Fessart D
Bull Cancer; 2022 Jan; 109(1):58-64. PubMed ID: 34903368
[TBL] [Abstract][Full Text] [Related]
16. Development of glioblastoma organoids and their applications in personalized therapy.
Xu C; Yuan X; Hou P; Li Z; Wang C; Fang C; Tan Y
Cancer Biol Med; 2023 Jun; 20(5):353-68. PubMed ID: 37283493
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived organoids as a model for tumor research.
Wang J; Feng X; Li Z; Chen Y; Huang W
Prog Mol Biol Transl Sci; 2022; 189(1):259-326. PubMed ID: 35595351
[TBL] [Abstract][Full Text] [Related]
18. Renal carcinoma/kidney progenitor cell chimera organoid as a novel tumorigenesis gene discovery model.
Xu Q; Junttila S; Scherer A; Giri KR; Kivelä O; Skovorodkin I; Röning J; Quaggin SE; Marti HP; Shan J; Samoylenko A; Vainio SJ
Dis Model Mech; 2017 Dec; 10(12):1503-1515. PubMed ID: 29084770
[TBL] [Abstract][Full Text] [Related]
19. Organoid Models and Applications in Biomedical Research.
Xinaris C; Brizi V; Remuzzi G
Nephron; 2015; 130(3):191-9. PubMed ID: 26112599
[TBL] [Abstract][Full Text] [Related]
20. Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.
Qu S; Xu R; Yi G; Li Z; Zhang H; Qi S; Huang G
Mol Biomed; 2024 Feb; 5(1):6. PubMed ID: 38342791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
